Standardization and validation of a high-efficiency liquid chromatography with a diode-array detector (HPLC-DAD) for voriconazole blood level determination

Standardization and validation of a high-efficiency liquid chromatography with a diode-array detector (HPLC-DAD) for voriconazole blood level determination

Introduction. A specialized service for antifungal blood level determination is not available in Colombia. This service is essential for the proper follow-up of antifungal therapies. Objective. To standardize and validate a simple, sensitive, and specific protocol based on high-performance liquid ch...

Full description

Bibliographic Details
Main Authors:	Juan D. Zapata, Diego H. Cáceres, Luz E. Cano, Catalina de Bedout, Sinar D. Granada, Tonny W. Naranjo
Format:	Article
Language:	English
Published:	Instituto Nacional de Salud 2024-03-01
Series:	Biomédica: revista del Instituto Nacional de Salud
Subjects:	antifungal agents voriconazole chromatography, high pressure liquid drug monitoring
Online Access:	https://revistabiomedica.org/index.php/biomedica/article/view/6959

Similar Items

Treatment of invasive fungal infections: stability of voriconazole infusion solutions in PVC bags
by: Andréa I.H. Adams, et al.

A case presentation of Voriconazole therapy in a brochopulmonary dysplasia
by: Elaheh Amini, et al.
Published: (2015-03-01)

A case presentation of Voriconazole therapy in a brochopulmonary dysplasia
by: Elaheh Amini, et al.
Published: (2015-03-01)

Ocular Inserts of Voriconazole-Loaded Proniosomal Gels: Formulation, Evaluation and Microbiological Studies
by: El-Emam GA, et al.
Published: (2020-10-01)

Sensibilidad a fluconazol y voriconazol de aislamientos de Candida spp., obtenidos de mucosa oral de pacientes con sida Sensitivity to Fluconazol and Voriconazol in Candida spp. isolates from the oral mucosa of HIV positive patients
by: Carolina Gutiérrez, et al.
Published: (2007-12-01)

In Vitro Stability of the Biological Activity of Voriconazole against <i>Acanthamoeba castellanii</i>
by: Barbara Czerniak Rodrigues, et al.
Published: (2023-06-01)

The epidemiology, genotypes, antifungal susceptibility of Trichosporon species, and the impact of voriconazole on Trichosporon fungemia patients
by: Shin-Huei Kuo, et al.
Published: (2021-09-01)

The Role of Plasma Trough Concentration of Voriconazole and Voriconazole N-Oxide in Its Hepatotoxicity in Adult Patients
by: Cheng L, et al.
Published: (2024-08-01)

In vitro susceptibilities of fungal isolates against amphotericin B and voriconazole in Aspergillus keratitis: A comparative study
by: Niranjan Nayak, et al.
Published: (2013-01-01)

Development and Optimization of Hyaluronic Acid-Poloxamer In-Situ Gel Loaded with Voriconazole Cubosomes for Enhancement of Activity against Ocular Fungal Infection
by: Nabil A. Alhakamy, et al.
Published: (2022-04-01)

Comparison of the antifungal effect of voriconazole and fluconazole on oral candidiasis before and during radiotherapy
by: Zahra Golestannejad, et al.
Published: (2022-01-01)

Nebulised surface-active hybrid nanoparticles of voriconazole for pulmonary Aspergillosis demonstrate clathrin-mediated cellular uptake, improved antifungal efficacy and lung retention
by: Ranjot Kaur, et al.
Published: (2021-01-01)

To compare the safety and efficacy of intrastromal voriconazole alone and in combination with intracameral voriconazole in intractable cases of fungal keratitis
by: Monika Dahiya, et al.
Published: (2023-08-01)

Voriconazole-induced periostitis
by: D.C. Fernández Ávila, et al.
Published: (2021-04-01)

Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against Candida albicans with a dimorphic switching model
by: Tian B, et al.
Published: (2017-09-01)

Uso de voriconazol en el período neonatal. Reporte de dos casos = Voriconazole use during the neonatal period. Report of two cases
by: Carvajal Kalil, Luis Fernando, et al.
Published: (2011-06-01)

Voriconazole-Induced Diffuse Periostitis
by: Simona Stefan, MD, et al.
Published: (2022-09-01)

Inflammation Affects Liver Function and the Metabolism of Voriconazole to Voriconazole-N-Oxide in Adult and Elderly Patients
by: Zaiming Liang, et al.
Published: (2022-04-01)

Voriconazole-induced periostitis post lung transplantation
by: Orla M. Murray, Bsc, et al.
Published: (2022-05-01)

Safety and recommendation of voriconazole for invasive pulmonary aspergillosis in severe liver disease patients: a retrospective cohort study
by: Xin Zhang, et al.
Published: (2025-01-01)

Pseudoporphyria Induced by Voriconazole in a 10-year-old Boy: A Case Report and Review of the Literature
by: Francesca Caroppo, et al.
Published: (2023-05-01)

Recurrent Acremonium infection in a kidney transplant patient treated with voriconazole: a case report Infecção recidivante por Acremonium em paciente transplantado renal tratado com voriconazol: relato de caso
by: Felipe Francisco Tuon, et al.
Published: (2010-08-01)

Voriconazole in Prevention and Treatment of Febrile Neutropenia
by: Hamidreza Taghva Masoumi, et al.
Published: (2018-02-01)

Voriconazole Use in Children: Therapeutic Drug Monitoring and Control of Inflammation as Key Points for Optimal Treatment
by: José María Valle-T-Figueras, et al.
Published: (2021-06-01)

Associated factors with voriconazole plasma concentration: a systematic review and meta-analysis
by: Xiaoqi Li, et al.
Published: (2024-08-01)

An appraisal of antifungal impacts of nano-liposome containing voriconazole on voriconazole-resistant Aspergillus flavus isolates as a groundbreaking drug delivery system
by: Parviz Hassanpour, et al.
Published: (2020-03-01)

Factors influencing plasma concentration of voriconazole and voriconazole- N-oxide in younger adult and elderly patients
by: Lin Cheng, et al.
Published: (2023-02-01)

High-Performance Liquid Chromatography for Ultra-Simple Determination of Plasma Voriconazole Concentration
by: Takeo Yasu, et al.
Published: (2022-09-01)

RP-HPTLC method for determination of Voriconazole in bulk and in cream formulation
by: Manali W. Jain, et al.
Published: (2017-02-01)

Voriconazole-induced hypokalemia and hyponatremia and their correlations with voriconazole trough concentration
by: CHENG Lin, et al.
Published: (2020-07-01)

Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic Review.
by: Hannah Yejin Kim, et al.
Published: (2020-06-01)

Bronchoscopic Voriconazole Instillation in Pulmonary Aspergilloma: A Single Center Experience
by: Prajowl Shrestha, et al.
Published: (2019-06-01)

Natamycin versus voriconazole for fungal keratitis
by: José Retamal, et al.
Published: (2018-12-01)

Subcutaneous phaeohyphomycosis due to Phialemoniopsis ocularis successfully treated by voriconazole
by: Guillaume Desoubeaux, et al.
Published: (2014-07-01)

Intravitreal Voriconazole for Treatment of Bilateral Endogenous Candida Chorioretinitis
by: Ha Eun Sim, et al.
Published: (2020-08-01)

Systematic Evaluation of Voriconazole Pharmacokinetic Models without Pharmacogenetic Information for Bayesian Forecasting in Critically Ill Patients
by: Simon Kallee, et al.
Published: (2022-09-01)

Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B
by: Nur Efe İris, et al.
Published: (2016-11-01)

Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring
by: Swiss Medical Weekly
Published: (2006-11-01)

The combined utilization of Chlorhexidine and Voriconazole or Natamycin to combat Fusarium infections
by: Tao Jiang, et al.
Published: (2020-09-01)

Successful Treatment of Lasiodiplodia theobromae Keratitis – Assessing the Role of Voriconazole
by: Stephen Tak-lun Li, et al.
Published: (2016-10-01)